Early versus Late Local Recurrences after Conservative Treatment of Breast Carcinoma: Differences in Primary Tumor Characteristics and Patient Outcome-Reference-Cited by-同舟云学术

Early versus Late Local Recurrences after Conservative Treatment of Breast Carcinoma: Differences in Primary Tumor Characteristics and Patient Outcome

Published:2006 Issue:5-6 Volume:71 Page:361-368
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Courdi A.,Largillier R.,Ferrero J.-M.,Lallement M.,Raoust I.,Ettore F.,Peyrottes I.,Chamorey E.,Balu-Maestro C.,Chapellier C.

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference24 articles.

1. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

2. Significance of ipsilateral breast tumour recurrence after lumpectomy

3. Local Recurrences and Distant Metastases After Conservative Breast Cancer Treatments: Partly Independent Events

4. Local and distant recurrence after conservative management of “very low-risk” breast cancer are dependent events: a 10-year follow-up

5. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic models for early and late tumor progression prediction in nasopharyngeal carcinoma: An analysis of 8292 endemic cases;Cancer Medicine;2022-10-27

2. Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy;Radiology;2017-09

3. Acute acalculous cholecystitis due to breast cancer metastasis to the cystic duct;Surgical Case Reports;2016-10-12

4. Late Axillary Recurrence After Negative Sentinel Lymph Node Biopsy is Uncommon;Annals of Surgical Oncology;2016-03-08

5. Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trial;Annals of Oncology;2015-06